NAVIFY® Decision Support portfolio is a fully integrated portfolio of scalable, secure workflow solutions and apps designed to support care teams with analytics and actionable insights.
NAVIFY portfolio solutions help streamline workflow, increase collaboration and standardize processes.
Explore our portfolio of products and apps that can help you support more personalized care.
Find out how NAVIFY portfolio can support more informed treatment decisions at your institution.
Read how physicians and institutions are delivering improved cancer care with the help of NAVIFY portfolio.
Our vision for oncology’s future is patient-centric, value-based and outcomes-driven. Our goals may be ambitious, but we have already made huge leaps in deepening our understanding of cancer biology and developing effective cancer therapies. Molecular and genomic profiling has uncovered more of the genetic origins of cancer.
Clinicians need real-time access to clinical trials, the latest clinical practice guidelines, and scientific and medical literature to make evidence-based treatment decisions. NAVIFY portfolio is a suite of interoperable, scalable workflows and apps that empower personalized patient care.
NAVIFY Tumor Board transforms collaborative decision-making by providing a single, comprehensive view of each patient and enabling access to all relevant data and curated resources. Aggregating data helps support more effective multidisciplinary meetings and more informed treatment decisions.
News & events
October 14, 2021
Roche will have both a diagnostics and pharma presence at HLTH21, joining other global leaders in health innovation.
Visit Roche at HLTH21, booth 201, amongst inspiring industry thought leaders and influencers coming together to forget the digital, sustainable future of healthcare delivery.
October 12, 2021
Announcing a new cloud-based secondary analysis solution, NAVIFY Mutation Caller
Request a demo of this new cloud-based secondary analysis solution with next-generation sequencing variant calling methods to support the Roche KAPA portfolio of Sample Prep Reagents.
August 2, 2021
Announcing the development of a new product that will help redefine the management of acute infections.
This new digital acute infection management solution is being designed to help streamline workflows, support real-time collaboration and analytics, and reduce the time it takes to bring appropriate therapy to patients with serious infections.
Interested in learning more?
Request a demo
